文献速递血栓与止血

高血小板计数与高红细胞压积与动脉及静脉血栓风险

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
PubMed 文献 · J Thromb Haemost · 2019-08-20

在哥本哈根一般人群研究中前瞻性随访108 521人(中位8年),评估高血小板计数或高红细胞压积与动脉、静脉血栓风险的关系。血小板计数最高5百分位者脑动脉血栓风险升高,红细胞压积最高5百分位者心脏动脉血栓风险升高,两者均与静脉血栓栓塞风险无关。

要点

  • 血小板计数>398×10⁹/L者脑动脉血栓风险升高,HR 1.77。
  • 红细胞压积女性>45%、男性>48%者心脏动脉血栓风险升高,HR 1.46。
  • 高血小板计数与高红细胞压积均与静脉血栓栓塞风险无关。

核心结论

  • 在一般人群中,高血小板计数与脑动脉血栓风险升高相关(约1.8倍),高红细胞压积与心脏动脉血栓风险升高相关(约1.5倍),两者均与静脉血栓栓塞风险无关。

研究设计与样本

  • 前瞻性队列研究,纳入哥本哈根一般人群研究108 521人,中位随访8年,入组时测定血小板计数与血红细胞压积。

主要发现

  • 血小板计数最高5百分位(>398×10⁹/L)vs 25–75百分位(231–316×10⁹/L):脑动脉血栓HR 1.77(95%CI 1.38–2.24),事件率38 vs 26/10 000人年;心脏动脉血栓HR 0.82(95%CI 0.61–1.11),事件率23 vs 28/10 000人年。
  • 红细胞压积最高5百分位(女>45%/男>48%)vs 25–75百分位(女38.1–42%/男41.1–45%):脑动脉血栓HR 1.27(95%CI 0.91–1.75),事件率40 vs 26/10 000人年;心脏动脉血栓HR 1.46(95%CI 1.06–2.00),事件率43 vs 25/10 000人年。
  • 高血小板计数与高红细胞压积均与静脉血栓栓塞风险无关;排除骨髓增殖性肿瘤个体后血栓风险结果相似。

关键数值与推荐

  • 血小板计数最高5百分位定义为>398×10⁹/L,参照组25–75百分位为231–316×10⁹/L。
  • 红细胞压积最高5百分位定义为女性>45%、男性>48%,参照组25–75百分位为女性38.1–42%、男性41.1–45%。

临床怎么用

  • 在一般人群中,血小板计数>398×10⁹/L与脑动脉血栓风险升高相关,红细胞压积女性>45%、男性>48%与心脏动脉血栓风险升高相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether high platelet count or high hematocrit predict risk of thrombosis in individuals from the general population. OBJECTIVES: We tested the hypothesis that individuals from the general population with high platelet count or high hematocrit have high risk of arterial and venous thrombosis. METHODS: We prospectively followed 108 521 individuals from The Copenhagen General Population Study for a median of 8 years. Platelet count and blood hematocrit were measured at study entry. RESULTS AND CONCLUSION: Multivariable adjusted hazard ratios for individuals with platelet counts in the top 5 percentiles (>398 × 109 /L) vs in the 25th-75th percentiles (231-316 × 109 /L) were 1.77 (95% confidence interval [CI], 1.38-2.24) for arterial thrombosis in the brain (38 and 26 events/10 000 person-years) and 0.82 (95%, 0.61-1.11) for arterial thrombosis in the heart (23 and 28 events/10 000 person-years). For individuals with hematocrit values in the top 5 percentiles (women/men: >45/>48%) vs the 25th-75th percentiles (women/men: 38.1-42/41.1-45%), hazard ratios were 1.27 (95% CI, 0.91-1.75) for arterial thrombosis in the brain (40 and 26 events/10 000 person-years) and 1.46 (95% CI, 1.06-2.00) for arterial thrombosis in the heart (43 and 25 events/10 000 person-years). Neither high platelet count nor high hematocrit was associated with risk of venous thromboembolism. When excluding individuals with myeloproliferative neoplasia from the main analyses, results on risk of thrombosis were similar. In this prospective study, high platelet counts were associated with 1.8-fold risk of arterial thrombosis in the brain, whereas high hematocrit was associated with 1.5-fold risk of arterial thrombosis in the heart.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Warny M, Helby J, Birgens HS, et al. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study. J Thromb Haemost. 2019. PMID: 31309714. doi:10.1111/jth.14574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。